CSL Ltd
ASX:CSL
CSL Ltd
Cash
CSL Ltd
Cash Peer Comparison
Competitive Cash Analysis
Latest Figures & CAGR of Competitors
Company | Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CSL Ltd
ASX:CSL
|
Cash
$1B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
Immutep Ltd
ASX:IMM
|
Cash
AU$94.3m
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Mesoblast Ltd
ASX:MSB
|
Cash
$77.1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Cash
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Cash
AU$123.2m
|
CAGR 3-Years
16%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Cash
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is CSL Ltd's Cash?
Cash
1B
USD
Based on the financial report for Dec 31, 2023, CSL Ltd's Cash amounts to 1B USD.
What is CSL Ltd's Cash growth rate?
Cash CAGR 10Y
4%
Over the last year, the Cash growth was -33%. The average annual Cash growth rates for CSL Ltd have been -25% over the past three years , 9% over the past five years , and 4% over the past ten years .